Single-Incision Laparoscopic Surgery (SILS) for hysterectomy for benign disease

Record ID 32014000402
English
Authors' recommendations: Approximately 600,000 women undergo hysterectomy each year in the United States. The most common indications for hysterectomy are leiomyomata (benign tumors of the uterine muscle) and adenomyosis (infiltration of the glandular tissue of the uterine lining into the muscular wall of the uterus). For women in whom vaginal hysterectomy is not feasible because of large uterine size, insufficient uterine mobility, intra-abdominal adhesions (scarring), or other reasons, total laparoscopic hysterectomy (TLH) may be performed rather than open abdominal hysterectomy. For TLH, the uterine cervix and body are detached from surrounding structures via the laparoscope, and the tissues are removed through the abdomen or vagina. In a variation of the TLH procedure called laparoscopically assisted vaginal hysterectomy (LAVH), the uterine cervix and body are detached via the laparoscope and vagina, and the tissues are removed through the vagina. In the traditional method of performing TLH or LAVH, 2 to 5 small incisions or ports are made in the lower abdomen. The surgeon places the laparoscope and other instruments through these openings to accomplish dissection, cutting, stapling, suturing, and removal of the uterine specimen. The patient is left with multiple small scars on the abdomen.
Details
Project Status: Completed
Year Published: 2013
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Humans
  • Hysterectomy, Vaginal
  • Laparoscopy
  • Genital Diseases, Female
Contact
Organisation Name: HAYES, Inc.
Contact Address: 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name: saleinfo@hayesinc.com
Contact Email: saleinfo@hayesinc.com
Copyright: 2013 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.